
    
      A prospective randomized controlled trial of patients with a presumptive diagnosis of acute
      urinary tract infection caused by Extended Spectrum Beta Lactamase-producing Escherichia coli
      or Klebsiella pneumoniae in Post-kidney transplantation. Intravenous (IV) antibiotic is
      initially given to all patients. After day 3, patients were randomized to receive either oral
      sitafloxacin (100 mg twice daily) or intravenous ertapenem. The course of treatment will
      complete within 14 days.
    
  